Malformations of the septum, outflow tract and aortic arch are the most common congenital cardiovascular defects and occur in mice lacking Cited2, a transcriptional coactivator of TFAP2. Here we show that Cited2 -/-mice also develop laterality defects, including right isomerism, abnormal cardiac looping and hyposplenia, which are suppressed on a mixed genetic background. Cited2 -/-mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays. We propose that an abnormal Nodal-Pitx2c pathway represents a unifying mechanism for the cardiovascular malformations observed in Cited2 -/-mice, and that such malformations may be the sole manifestation of a laterality defect.
Genetic, developmental and molecular studies over the past decade have identified a number of DNA-binding transcription factors that have key roles in cardiac morphogenesis and in the pathogenesis of common congenital heart defects 1 . The role of transcriptional coactivators, molecules that connect DNA-binding transcription factors to the core transcriptional machinery, in cardiac development has only recently become apparent. These coactivators are exemplified by the paralogous genes EP300 and CREBBP 2 . Mutations in CREBBP cause Rubinstein-Taybi Syndrome 3 and are frequently associated with cardiac malformations 4 .
EP300 and CREBBP interact with high affinity with a ubiquitously expressed cytokine and hypoxia-inducible transcriptional coactivator called CITED2 (also called p35srj and Mrg1) [5] [6] [7] [8] . Binding of CITED2 to EP300 competitively inhibits the binding of the transcription factor HIF1A to EP300, blocking hypoxia-activated gene transcription 5, 8 . Cited2 is essential for normal development of the heart, adrenals and nervous system [9] [10] [11] [12] [13] and for fibroblast proliferation 14 . Mice lacking Cited2 die prenatally with diverse cardiovascular malformations, including atrial and ventricular septal defects, double-outlet right ventricle, common arterial trunk and aberrant aortic arches.
In addition to functioning as a transcriptional repressor of HIF1A, CITED2 also physically interacts with and coactivates TFAP2 (transcription factor AP2, also called Tcfap2) and LIM-domain containing transcription factors by linking them to EP300 and CREBBP 9, 15, 16 . Mutations in Tcfap2a and TFAP2B (Char syndrome) result in cardiac and aortic arch malformations 17, 18 , suggesting that coactivation of TFAP2 by CITED2, EP300 and CREBBP is necessary for the normal development of these structures 9 . An alternative explanation for the development of cardiac malformations in mice lacking Cited2 is dysregulation of hypoxia-activated gene transcription 12 .
The cardiovascular malformations resulting from deficiency of Cited2 encompass a diverse and variable spectrum that is not explained by effects on a single developmental process. For instance, although the deficiency of neural crest cells expressing Erbb3 in Cited2 À/À embryos explains abnormal aortic arch remodeling 9 , it does not explain the atrioventricular septal defects. Cited2 may be independently required for different aspects of cardiovascular development, with phenotypic variability resulting from random segregation of genetic modifiers. To test this idea, we characterized the cardiac phenotypes of coisogenic C57BL/6J Cited2 À/À embryos. We found that the C57BL/6J background had a marked effect on the phenotype of Cited2 À/À mice, resulting in left-right patterning defects. These results indicate that Cited2 has a previously unsuspected role in establishing embryonic laterality and provide a unifying mechanism that explains the development of the diverse cardiovascular malformations in mice lacking Cited2.
RESULTS
Left-right patterning defects in Cited2 À/À embryos We characterized Cited2 À/À embryos on mixed (129Ola Â C57BL6/J) and coisogenic C57BL/6J backgrounds using magnetic resonance imaging (MRI). In addition to the heart and aortic arch defects previously reported 9, 11, 12 , these embryos had abnormal left-right patterning ( Table 1) . The left-right patterning abnormalities were significantly more frequent in coisogenic C57BL/6J (7 of 11) than in mixed-background (3 of 15) Cited2 À/À embryos (w 2 ¼ 5.1, P r 0.025). The abnormalities included right atrial isomerism (Fig. 1c,d ), cardiac dextroposition (Fig. 1c) , bilateral or midline inferior caval vein (Fig. 1d) , abnormalities in ventricular topology (Fig. 1g-j) , right pulmonary isomerism (Fig. 2b,d ), small or rudimentary spleens (Fig. 2f) , and abnormal embryonic turning (assessed at 9.5-10.5 d post coitum (d.p.c.), Fig. 2j ). In 1 Cited2 À/À embryo (of 26 studied by MRI) we observed abdominal visceral situs inversus (Fig. 2h) . These malformations were not observed in wild-type embryos from either genetic background (Figs. 1a,b ,e,f and 2a,c,e,g,i). We used Hand1 (also called eHand) riboprobes to mark the left ventricle 19 and found that it was positioned either posterior or dextral to the right ventricle in C57BL/6J Cited2 À/À embryos, confirming that they had ventrally or sinistrally looped hearts ( Fig. 3b,d ; compare with wild-type hearts in Fig. 3a,c) .
Pitx2c is deficient in C57BL6/J Cited2 À/À embryos A key feature of the phenotype of C57BL6/J Cited2 À/À embryos, right isomerism and hyposplenia, also occurs in mice lacking Pitx2, a homeobox transcription factor [20] [21] [22] [23] . This left-determining activity specifically resides in the Pitx2c isoform, which is expressed asymmetrically in the left lateral plate mesoderm at 8.5 d.p.c. and later in the developing heart, lungs and gut 21, 24 . Consistent with previous observations 21 , we detected Pitx2 asymmetrically in the left lateral plate mesoderm and symmetrically in the head mesoderm in wild-type embryos at 8.5 d.p.c. (Fig. 3e,f) . In C57BL6/J Cited2 À/À embryos, Pitx2 expression in the left lateral plate mesoderm was typically lost (in 9 of 11 embryos) whereas expression in the head mesoderm was normal, indicative of a specific deficiency of Pitx2c (Fig. 3g,h ). Consistent with previous observations 21, 25 , Pitx2c was expressed over the outflow tract and ventral surface of the right ventricle and in the left atrium in hearts of wild-type embryos (Fig. 3i,j) but was deficient in hearts of C57BL6/J Cited2 À/À embryos (three of three; Fig. 3k,l) .
Effect of genetic background on Pitx2c expression
To investigate the relative paucity of right isomerism in the mixed genetic background, we crossed coisogenic C57BL6/J Cited2 +/-and coisogenic 129Sv Cited2 +/-mice. Pitx2c expression in the left lateral plate mesoderm of mixed-background Cited2 À/À embryos (F 1 generation, 8.5 d.p.c.) resembled that of the wild-type embryos (11 of 11; Fig. 3m-p) , consistent with the reduced frequency of isomerism observed in the mixed background. Pitx2c expression in hearts of mixed-background F 1 Cited2 À/À embryos resembled that of the wildtype embryos in two of three cases (Fig. 3q,r) . In the third case, Pitx2c expression was reduced in the outflow tract and right ventricle but preserved in the left atrium (Fig. 3s,t) . Examination of mixed-background F 1 Cited2 À/À embryos at later stages by MRI indicated that they have cardiac abnormalities, such as ventricular septal defects and double-outlet right ventricle, but not laterality defects (three of three embryos; data not shown). The mixed-background F 1 Cited2 À/À embryos (seven of seven) turned normally (data not shown).
Cardiac and laterality defects in Pitx2c À/À embryos To determine the extent to which the C57BL6/J Cited2 À/À phenotype can be explained by Pitx2c deficiency, we examined Pitx2c À/À embryos, which specifically lack the Pitx2c isoform 25 and have defects in the aortic arch vessels, such as double-outlet right ventricle and right-sided or double aortic arches 25 . We found that 11 of 18 Pitx2c À/À embryos had bilateral, left-sided or midline inferior caval veins (Fig. 4a) , and 16 of 18 embryos had right atrial and pulmonary isomerism (Fig. 4b,c) . Although none had abnormal ventricular topology, 7 of 18 embryos had malposition of the heart to the right (Fig. 4d) , and the hearts of the remaining embryos were in the midline rather than to the left. In addition, 16 of 18 embryos had ventricular septal defects with associated double-outlet right ventricle (Fig. 4e) , and 3 of 18 embryos had right-sided aortic arches. Notably, we observed that 2 of 18 Pitx2c À/À embryos had right-sided stomachs (Fig. 4f) , and 1 of 18 had a midline stomach. The spleen was absent or small in 16 of 18 embryos. Unlike mice lacking all Pitx2 isoforms 21, 22 , none of the Pitx2c À/À embryos had defects in ventral body wall closure (Fig. 4d,f) .
Cited2 is required for Nodal-activated transcription The asymmetric expression of Pitx2c in the left lateral plate mesoderm is controlled by Nodal, a TGF-b-like molecule. Nodal is expressed in the node and induces the asymmetric expression of Pitx2c, Ebaf (also called Lefty2) and Nodal in the left lateral plate mesoderm 26, 27 . Nodal was absent in the left lateral plate mesoderm (in 7 of 8 embryos) but present in the node of C57BL6/J Cited2 À/À embryos, though at lower levels than in wild-type embryos ( Fig. 5a-d) . Ebaf, which functions as a Nodal antagonist 28, 29 and is normally expressed in the left lateral plate mesoderm, was also absent in C57BL6/J Cited2 À/À embryos (six of six; Fig. 5e ,f). Cfc1 (also called Cryptic), a coreceptor for Nodal, was, in keeping with previous observations 30 , expressed in the lateral plate mesoderm in wild-type and C57BL6/J Cited2 À/À embryos (two of two; Fig. 5g,h ). Leftb (also called Lefty1), a Nodal antagonist that is normally expressed on the left side of the prospective floorplate in response to Nodal 31 , was restricted to the posterior floorplate in C57BL6/J Cited2 À/À embryos (two of two; Fig. 5i-l) . TFAP2 and CITED2 interact with the Pitx2c P1 promoter To further examine the deficiency of Nodal-activated gene transcription in C57BL6/J Cited2 À/À mice, we focused on Pitx2c. Pitx2c expression during development is controlled by an asymmetric enhancer (ASE) and a P1 promoter 32 (Fig. 6 ). Because one mechanism for CITED2 function is coactivation of TFAP2, we used the transcription factor database 33 to identify putative TFAP2 binding sites in the mouse and human promoters 32 ( Fig. 6b) . Alignment of the mouse and human Pitx2c P1 promoters also showed that they are extensively conserved (Fig. 6b) . Using RT-PCR, we found that Tcfap2 isoforms, Cited2 and Pitx2c were coexpressed in C2C12 cells and in the embryonic heart (Supplementary Fig. 1 online). To determine whether endogenous CITED2 and TFAP2 physically interact with the Pitx2c P1 promoter and the ASE, we carried out chromatin immunoprecipitation (ChIP) assays, initially from C2C12 cells. We reproducibly detected specific ChIP signals with antibodies specific to TFAP2A, TFAP2C and CITED2 (Fig. 7a) . We were unable to detect ChIP signals using primers in the ASE (data not shown). We next carried out ChIP assays from wild-type embryonic hearts at 13.5 d.p.c. We detected specific and reproducible signals (in three independent experiments) with antibodies specific to acetylated histone H3, TFAP2A and CITED2 (Fig. 7b) .
TFAP2 and CITED2 activate the Pitx2c P1 promoter To determine whether TFAP2 and CITED2 could directly activate the Pitx2c P1 promoter, we constructed a luciferase reporter vector (P1-Luc-ASE) that maintains the relative arrangement of the P1 and the ASE elements with respect to the transcriptional start site 32 . We also constructed a reporter vector that has P1 but lacks the ASE (P1-Luc), carried out transient transfection experiments in Hep3B cells and measured luciferase reporter activity. P1-Luc activity was not affected by CITED2 alone (Fig. 7c) but was activated by TFAP2A (by a factor of 1.9) and by TFAP2C (by a factor of 2.7). P1-Luc activity was further activated by TFAP2A plus CITED2 (by a factor of 2.6) and by TFAP2C plus CITED2 (by a factor of 3.5). The baseline reporter activity of P1-Luc-ASE was not affected by CITED2 alone. It was activated weakly by TFAP2A (by a factor of 1.2) and significantly more strongly by TFAP2A plus CITED2 (by a factor of 1.9). It was activated more strongly (by a factor of 2.0) by TFAP2C and, again, significantly TFAP2 binding sites in the Pitx2c P1 promoter To identify TFAP2 binding sites in the Pitx2c P1 promoter, we tested radioactively labeled double-stranded oligonucleotide probes (AB-WX; Fig. 6b ) for binding to TFAP2A (generated by coupled in vitro transcription-translation using reticulocyte lysates) by electrophoretic mobility shift assay (EMSA). The addition of probes IJ, MN and QR to reticulocyte lysate containing TFAP2A resulted in the appearance of a specific band (Fig. 7d ) that is competed out by a wild-type TFAP2 binding probe (MTIIa) but not by mutant or nonspecific probes (MTIIaMUT or PPAR). We obtained similar results for TFAP2C (data not shown). We next investigated the role of the TFAP2 binding sites IJ, MN and QR in promoter transcriptional activity by mutating them to prevent TFAP2 binding. Loss of TFAP2 binding by the mutant oligonucleotides was confirmed by EMSA (data not shown). We next introduced the IJ, MN and QR mutations in the Pitx2c P1 promoter by site-directed mutagenesis. The mutations were introduced in the 0.9-P1 vector 32 and their effect examined in transient transfection experiments. The transcriptional activity of the construct containing the wildtype Pitx2c promoter (0.9-P1) was significantly increased by the cotransfection of TFAP2 and CITED2. Mutations of the IJ, MN and QR TFAP2 binding sites (0.9-P1(IJMNQR)) led to significant decrease of reporter activation by TFAP2 isoforms in combination with CITED2 (Fig. 7e) .
DISCUSSION
Our results, together with those reported previously 9, [11] [12] [13] , show that on a mixed background, Cited2 À/À embryos have a variable spectrum of cardiovascular malformations with defects in atrioventricular septation, outflow tract formation and aortic arch remodeling. Coisogenic C57BL/6J Cited2 À/À embryos also develop a spectrum of left-right patterning abnormalities at a significantly high frequency, indicating that background-specific genetic modifiers have a key role in determining the phenotype. The appearance of diverse cardiac malformations in the mixed genetic background could then be a subtle manifestation of an underlying left-right patterning abnormality. The left-right patterning defect in Cited2 À/À embryos was characterized by right isomerism and hyposplenia, which are prominent features of Pitx2 deficiency [20] [21] [22] [23] [24] . Our results using Pitx2c À/À mice definitively establish that these functions of Pitx2 reside in the asymmetrically expressed Pitx2c isoform. The loss of Pitx2c expression in C57BL/6J Cited2 À/À embryos indicates that Cited2 functions genetically upstream of Pitx2c. Thus, the abnormal caval veins, right atrial and pulmonary isomerism, ventricular septal defects with double-outlet right ventricle, right-sided aortic arches, cardiac dextroposition, hyposplenia and occasional visceral situs inversus observed in C57BL/6J Cited2 À/À embryos can be explained by Pitx2c deficiency. Notably, Pitx2c deficiency is not apparent in the left lateral plate mesoderm of mixed-background F 1 Cited2 À/À embryos, explaining the lack of overt laterality defects. But expression of Pitx2c in the hearts of mixed-background F 1 Cited2 À/À embryos can be abnormal, explaining the other cardiovascular malformations observed here. These results indicate that genetic modifiers of the Cited2 À/À phenotype function by directly or indirectly controlling Pitx2c transcription.
The asymmetric expression of Pitx2c in the left lateral plate mesoderm is controlled by Nodal, a TGF-b-like molecule that is expressed in the node and then in the left lateral plate mesoderm 26, 27, 34 . Nodal activity is thought to travel from the node to the left lateral plate mesoderm, and from the left lateral plate mesoderm to the midline 31 . The binding of Nodal to its receptor-coreceptor complex (consisting of Acvr2b, Acvr1b and Cfc1) results in phosphorylation of Smad2 (ref. 26) . Phosphorylated Smad2 interacts with the transcription factor Foxh1 to activate target gene transcription through the asymmetric enhancers of Pitx2c, Nodal and Ebaf, thus mediating the Nodal-induced expression of these genes in the left lateral plate mesoderm 29, 31, 32, 35 . Our data indicate that in C57BL/6J Cited2 À/À embryos, although Nodal is expressed in the node, both Nodal and Ebaf are absent in the left lateral plate mesoderm. The absence of Pitx2c, Ebaf and Nodal in the left lateral plate mesoderm of C57BL/6J Cited2 À/À embryos indicates that Cited2 is necessary for Nodal-activated gene transcription at this location.
Genetic evidence suggests that Cited2 functions, at least in part, downstream or in parallel to Cfc1. Deletion of Cfc1 results in right isomerism, hyposplenism, abnormal cardiac looping and randomization of axial rotation and of visceral situs 36, 37 . It also results in loss of Pitx2c, Ebaf and Nodal in the left lateral plate mesoderm and loss of Leftb in the left posterior floorplate, but with preservation of Nodal expression in the node 36, 37 . C57BL/6J Cited2 À/À embryos resemble those with Cfc1 deficiency, with three exceptions: (i) they do not have randomization of visceral situs; (ii) they have only partial loss of Leftb expression; and (iii) they express Cfc1 normally. Taken together, our data are most consistent with Cited2 functioning, at least in part, downstream or in parallel to Cfc1 and upstream of Nodal, Pitx2c and Ebaf in the left lateral plate mesoderm. Notably, mutation causing One mechanism explaining these results is that CITED2, a transcriptional coactivator for TFAP2 and LIM-domain transcription factors 9, 15, 16 , may coactivate Nodal-activated gene transcription in the left lateral plate mesoderm. In support of this idea, in the case of Pitx2c, we showed that endogenous CITED2 and TFAP2 can be detected at the Pitx2c P1 promoter in embryonic hearts and C2C12 cells. We also showed that acetylated histone H3 is present at the Pitx2c P1 promoter, indicating that it is in a transcriptionally active state. In addition, we showed that the Pitx2c P1 promoter contains evolutionarily conserved TFAP2 binding sites, that sequences from the Pitx2c P1 promoter directly bind TFAP2 in vitro and that TFAP2 activates and CITED2 coactivates the Pitx2c P1 promoter in transfection assays. Our experiments also identify certain TFAP2 binding sites in the Pitx2c P1 promoter that are necessary for TFAP2 and CITED2-mediated activation. These results do not however exclude the possibility that endogenous CITED2 or TFAP2 may be recruited to the Pitx2c P1 promoter independently of these TFAP2 binding sites, for example, through Sp1 or LIM-domain transcription factors 16, 38 .
Our results also show that the mouse and human Pitx2c P1 promoters are highly conserved, with large blocks of sequence identity of 85% or more. Genome-wide comparisons between human and mouse indicate that the average sequence identity is 69% in introns, 75% in untranslated regions and 85% in coding regions 39 . The high degree of sequence conservation of the Pitx2c P1 promoter suggests that its functions have been evolutionarily conserved under natural selection over B75 million years of mammalian species divergence. This is probably important, as the characteristic features of the mammalian heart (complete atrial, ventricular and outflow tract septation, and left-sidedness of the aortic arches 40 ) are controlled by Pitx2c 25 .
In conclusion, these results establish new roles for Cited2 in controlling left-right patterning and Nodal-activated gene transcription. They show that the cardiovascular and laterality defects in Cited2 À/À embryos can be explained by a deficiency of the NodalPitx2c pathway, providing a unifying mechanism for the apparently unrelated malformations of the cardiac septum, outflow tract and aortic arch previously observed in Cited2-deficient mice. These cardiovascular malformations were hitherto not recognized as laterality defects. Our results indicate the existence of genetic modifiers that affect the development of overt laterality defects such as isomerism. Moreover, they show that Pitx2c is required for the development of the characteristic features of the mammalian heart and suggest that the control of Pitx2c expression is conserved through mammalian evolution. Our results imply that common congenital heart defects, such as cardiac septal, outflow tract and aortic arch malformations 41 , may be the sole manifestation of a laterality defect and suggest that mutations in genes controlling laterality may result in common forms of congenital heart disease.
METHODS
Embryos and MRI. We backcrossed Cited2 +/-mice (Cited2 tmBha1 , 129P2OlaHsd Â C57BL/6J 9 ) to C57BL/6J and to 129Sv mice for nine generations to generate coisogenic mice. Pitx2c +/-mice were described previously 25 . We collected embryos at the indicated time points after detection of a vaginal plug (0.5 d.p.c.) and genotyped them using allele-specific PCR (primer details available on request). We carried out MRI and data analysis as described previously 13 , with a final image resolution of either 12.7 Â 12.7 Â 19.5 mm per voxel or 25.4 Â 25.4 Â 24.4 mm per voxel (x, y and z axes). All animal experimentation was done under UK Home Office authorization and regulations.
In situ hybridization. We carried out in situ hybridization essentially as described 42 using digoxigenin-UTP-labeled riboprobes (Roche). The Hand1 probe was a gift from P. Riley (ICH, London) and the Pitx2 probe was described previously 43 . Nodal, Leftb, Ebaf and Cfc1 probes were gifts from H. Hamada (Osaka University, Japan).
DNA sequence analysis. We identified transcription factor binding sites using DNAStar software and SignalScan TFD 33 . The consensus TFAP2 binding sites are S00346, YCSCCMNSSS; S01544, GSSWGSCC; and S01936, CCCMNSSS. We carried out BLAST analysis as described 44 . The mouse and human Pitx2c P1 promoter sequences correspond to Ensembl mouse chromosome 3 132825298-132826982 and human chromosome 4 112004151-112002466.
Plasmids. CMV-CITED2, CMV-TFAP2A, CMV-TFAP2C, CMV-luciferase and CMV-lacZ were described previously 5, 9 . We constructed plasmids P1-Luc-ASE and P1-Luc by subcloning appropriate fragments from plasmid 0.9-P1 (gift from H. Hamada and H. Shiratori 32 , Osaka University, Japan) into pGL3Basic (Promega) using standard techniques 45 (Supplementary Methods online). We mutated the TFAP2 binding sites in oligonucleotides IJ and QR and the second TFAP2 binding site in oligonucleotide MN (the first site did not bind TFAP2 in vitro) using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) and confirmed them by sequencing. Oligonucleotide and plasmid details are available on request.
Antibodies. We obtained affinity-purified monoclonal antibodies specific to CITED2 and Stat1 from Novus Biologicals 5 (JA22, IgG1) and from Santa Cruz Biotechnology (C-136, sc-464X, IgG1). TFAP2A-specific rabbit polyclonal antibody HCH16 and preimmune serum were gifts from H. Hurst (CRUK, London). We obtained polyclonal antibodies to TFAP2A (C-18, sc-184X), TFAP2C (H-77, sc-8977X), Stat2 (C-20, sc-476X) and Flag (D-8, sc-807) from Santa Cruz Biotechnology. We obtained antibody to acetylated histone H3 (06-599) from Upstate Cell Signalling Solutions and polyclonal antibody to mouse IgG (Z0109) from DAKO.
Cells and transfections. We obtained C2C12 and Hep3B cells from ATCC. We transfected cells and measured luciferase and b-galactosidase activities the next day as described 15 . We assessed statistical significance using the t-test, using P r 0.05 as statistically significant.
ChIP assays and EMSA. We carried out ChIP essentially as described 46 from C2C12 cells or hearts isolated from embryos at 13.5 d.p.c. using the indicated primary antibodies and a secondary polyclonal antibody to mouse IgG for primary monoclonal antibodies (Supplementary Methods online). We carried out EMSA as described 15 . MTIIa is a wild-type TFAP2 binding site from the metallothionein IIa gene promoter. MTIIaMUT contains a mutation that abolishes binding, and PPAR contains a PPARg binding site. Oligonucleotide sequences are available on request.
URLs. SignalScan TFD is available at http://bimas.cit.nih.gov/molbio/. 2-Sequence BLAST is available at http://www.ncbi.nlm.nih.gov/blast/bl2seq/ bl2.html.
Note: Supplementary information is available on the Nature Genetics website.
